Prudential Financial
ADMA icon

Prudential Financial’s ADMA Biologics ADMA Stock Holding History

Prudential Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
239,805
-67,245
-22% -$613K ﹤0.01% 1402
2026
Q1 		$2.77M Sell
307,050
-18,300
-6% -$289K ﹤0.01% 1180
2025
Q4 		$5.93M Sell
325,350
-116,480
-26% -$1.96M 0.01% 842
2025
Q3 		$6.48M Sell
441,830
-56,870
-11% -$975K 0.01% 803
2025
Q2 		$9.08M Buy
498,700
+665
+0.1% +$13.6K 0.01% 674
2025
Q1 		$9.88M Sell
498,035
-26,395
-5% -$456K 0.01% 593
2024
Q4 		$8.99M Buy
524,430
+5,897
+1% +$111K 0.01% 653
2024
Q3 		$10.4M Buy
518,533
+122,959
+31% +$1.91M 0.01% 666
2024
Q2 		$4.42M Buy
395,574
+359,238
+989% +$3.01M 0.01% 984
2024
Q1 		$240K Buy
36,336
+22,746
+167% +$124K ﹤0.01% 2417
2023
Q4 		$61.4K Buy
13,590
+550
+4% +$2.04K ﹤0.01% 2533
2023
Q3 		$46.7K Hold
13,040
– – ﹤0.01% 2508
2023
Q2 		$48.1K Buy
13,040
+980
+8% +$3.63K ﹤0.01% 2539
2023
Q1 		$39.9K Buy
12,060
+310
+3% +$1.07K ﹤0.01% 2520
2022
Q4 		$45.6K Sell
11,750
-3,700
-24% -$11.4K ﹤0.01% 2500
2022
Q3 		$38K Sell
15,450
-17,200
-53% -$41.3K ﹤0.01% 2584
2022
Q2 		$65K Buy
+32,650
New +$64.2K ﹤0.01% 2554
2021
Q2 		– Sell
-12,909
Closed -$23K – 2548
2021
Q1 		$23K Buy
12,909
+1,980
+18% +$4.53K ﹤0.01% 2477
2020
Q4 		$21K Hold
10,929
– – ﹤0.01% 2436
2020
Q3 		$26K Buy
+10,929
New +$30K ﹤0.01% 2409

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Prudential Financial's ADMA Position: Q2 2026 in Review

Prudential Financial reduced its ADMA Biologics (ADMA) stake by 22% in Q2 2026, selling an estimated $613K and leaving 239,805 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

Prudential Financial first reported a position in ADMA in Q3 2020 and has held it in 20 quarters since. The position peaked at $10.4M in Q3 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Prudential Financial held 239,805 shares of ADMA Biologics worth $2.01M as of Q2 2026.
  • Prudential Financial sold 67,245 ADMA Biologics shares in Q2 2026, an estimated $613K.
  • ADMA Biologics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1402 holding.
  • Prudential Financial first reported a position in ADMA Biologics in Q3 2020 and has held it in 20 quarters since.
  • Prudential Financial's ADMA Biologics position peaked at $10.4M in Q3 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.